Status:
NOT_YET_RECRUITING
Pulmonary Arterial Hypertension and Associated Cardiovascular Disease Detection Using Artificial Intelligence
Lead Sponsor:
Imperial College London
Collaborating Sponsors:
Imperial College Healthcare NHS Trust
Conditions:
Pulmonary Hypertension
Cardiovascular Diseases (CVD)
Eligibility:
All Genders
18+ years
Brief Summary
Cardiovascular disease (CVD) is a leading global cause of morbidity and mortality and excessive healthcare expenditures. Pulmonary hypertension (PH) represents an insidious and progressive subset of C...
Detailed Description
This prospective observational cohort and validation study aims to create a patient dataset of point-of-care cardiovascular waveforms for validation of Imperial College London artificial intelligence ...
Eligibility Criteria
Inclusion
- Age 18 years or above
- Able to give informed consent
- Attending for echocardiography at Imperial College NHS Trust
Exclusion
- • Any chest wound, skin pathology or other feature that would prohibit routine stethoscope examination
Key Trial Info
Start Date :
October 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2027
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT07147725
Start Date
October 1 2025
End Date
August 1 2027
Last Update
September 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Imperial College Healthcare NHS Trust
London, United Kingdom